Metropolis Healthcare Announces Landmark 3:1 Bonus Issue: First-Ever Reward for Shareholders in 2026

Leading diagnostic services provider

lis Healthcare Ltd. (NSE: METROPOLIS, BSE: 542650) has solidified its commitment to shareholder value with its inaugural bonus issue, announced earlier this year and now progressing toward execution. On February 4, 2026, the company's Board of Directors recommended and approved the issuance of bonus equity shares in a generous 3:1 ratio. This means eligible shareholders will receive three fully paid-up equity shares of face value ₹2 each for every one fully paid-up equity share of ₹2 face value held as on the record date. The proposal, detailed in an exchange filing, was made subject to necessary member, statutory, and regulatory approvals. This marks the first-ever bonus issue in the company's history, reflecting confidence in its financial strength and growth trajectory amid a robust performance in the healthcare diagnostics sector. The bonus shares will be issued from the company's free reserves, requiring approximately ₹31.09 crore for capitalization, with an estimated issuance of over 15.54 crore bonus shares. Following shareholder approval through postal ballot and remote e-voting, Metropolis Healthcare fixed March 20, 2026, as the record date for determining eligibility. The ex-bonus date aligns accordingly, meaning investors must hold shares by the close of trading on the record date to qualify. Bonus shares are expected to be credited or dispatched on or before April 3, 2026.